| 000 | 00995 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250514071106.0 | ||
| 264 | 0 | _c20030627 | |
| 008 | 200306s 0 0 eng d | ||
| 022 | _a1470-2045 | ||
| 024 | 7 |
_a10.1016/s1470-2045(03)01132-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrizel, David M | |
| 245 | 0 | 0 |
_aDoes amifostine have a role in chemoradiation treatment? _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _cJun 2003 |
||
| 300 |
_a378-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAmifostine _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aRadiation Injuries _xprevention & control |
| 650 | 0 | 4 |
_aRadiation-Protective Agents _xtherapeutic use |
| 700 | 1 | _aOvergaard, Jens | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 4 _gno. 6 _gp. 378-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1470-2045(03)01132-x _zAvailable from publisher's website |
| 999 |
_c12573730 _d12573730 |
||